BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

933 related articles for article (PubMed ID: 12425487)

  • 1. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
    Hasegawa M; Kawamura N; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Hasegawa H; Shikano M; Mizuno M; Funahashi N; Kawashima S; Sugiyama S
    Nihon Jinzo Gakkai Shi; 2002; 44(5):453-63. PubMed ID: 12216478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 2002 Jun; 17(6):1063-9. PubMed ID: 12032198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [No Abstract]   [Full Text] [Related]  

  • 5. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin.
    Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
    Ahluwalia N; Skikne BS; Savin V; Chonko A
    Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
    Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double diagnostic meaning of serum transferrin receptor in hemodialysis patients: two case reports.
    Passanante S; Diquattro M; Greco V; Li Cavoli G; Bono L; Palma B; Scola S; Faraci C; Rotolo U; Menozzi I
    Lab Hematol; 2004; 10(2):61-4. PubMed ID: 15224760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
    Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients.
    Tsuchiya K; Okano H; Teramura M; Iwamoto Y; Yamashita N; Suda A; Shimada K; Nihei H; Ando M
    Clin Nephrol; 2003 Feb; 59(2):115-23. PubMed ID: 12608554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemia.
    Choi JW; Son BK
    Clin Chim Acta; 2005 May; 355(1-2):83-9. PubMed ID: 15820481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements.
    Lorenzo JD; Rodríguez MM; Martín SS; Romo JM
    Am J Kidney Dis; 2001 Mar; 37(3):550-6. PubMed ID: 11228179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan.
    Matsuda A; Bessho M; Mori S; Takeuchi T; Abe T; Yawata Y; Mori H; Omine M; Nakamura Y; Furusawa S; Maeda T; Haginosita S; Hirasawa Y; Kinugasa E; Akizawa T; Kawakami N; Nagata A; Hirashima K
    Haematologia (Budap); 2002; 32(3):225-38. PubMed ID: 12611483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients.
    Beerenhout C; Bekers O; Kooman JP; van der Sande FM; Leunissen KM
    Nephron; 2002 Sep; 92(1):32-5. PubMed ID: 12187081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is serum transferrin receptor a sensitive marker of iron repletion in patients with iron-deficiency anemia and hemodialysis patients?
    Hou CC; Wu SC; Wu SC; Chen TW; Yang WC; Ng YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):189-94. PubMed ID: 10367478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.